SUN PHARMA ADV.RES.CO.LTD
SPARC.NS
₹ 211.97
2%
Sun Pharma Advanced Research Co Ltd
Sun Pharma Advanced Research Co Ltd is a Small Cap stock that belongs to the Miscellaneous sector. The current live share price of SPARC Ltd is ₹ 211.97 that is ₹ 3.26 -1.51% with respect to the previous day’s close price. The stock price of SPARC Ltd was last updated 12 hours ago.
SPARC Ltd Stock Price Performance
In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.
SPARC Ltd Live Share Price Analysis
SUN PHARMA ADV.RES.CO.LTD
₹ 211.97
Open ₹ 215.00
High ₹ 215.23
Marketcap 69.43B
Close ₹ 211.97
Low ₹ 208.76
Volume ₹ 284,367.00
The stock of Sun Pharma Advanced Research Co Ltd strated the trade at an Open price of ₹ 215.00 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 215.23 and an Intraday Low price of ₹ 208.76%. As per last updated 12 hours ago, the Shares of SPARC Ltd were trading at a price of ₹ 211.97 which is ₹ 3.26 -1.51% as compared the price ₹ 215.23 at which the stock close on the previous trading day. The total traded volume for the day stood at 284,367 number of shares.
Candlestick Chart of SPARC Ltd Share Price Movements
The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).
Historical Performance of SPARC Ltd Shares
| 52 Week Range | Price | 52 Weeks Low | 52 Weeks High |
|---|---|---|---|
| ₹ 211.97 | ₹ 189.75 | ₹ 472.80 |
Here is SPARC Ltd’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 472.80. On the lower side, the stock has been to the 52 weeks low price level of ₹ 189.75. It’s last traded price was ₹ 211.97 as on last update 12 hours ago. The one-year line chart clearly shows how the price of SPARC Ltd’s stock has moved in the last twelve months.
The Company has posted an earnings of ₹ -12.59 per share (EPS TTM) in the trailing twelve months period. SPARC Ltd’s last annual dividend rate was %, which translates to a % of annual dividend yield.
Line Chart of SPARC Ltd Stock Price
Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.
Companies Similar to SPARC Ltd
Sun Pharma Advanced Research Co Ltd belongs to the Miscellaneous sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to SPARC Ltd are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.
Share Price Snapshot Companies Similar to SPARC Ltd
Select list of companies is given below. To view more about the Industry and see other companies from Miscellaneous Industry, click on the industry name.
BOMBCYC.BOBOMBAY CYCLE & MOTOR AGENCY LT
₹ 1,969.20
BSE₹ 0.0000
0.00%About SPARC Ltd
Sun Pharma Advanced Research Co Ltd is a Sun Pharma Group Company. The company operates in the Miscellaneous sector. Incorporated in 2006, it has around 15 years of operations. SPARC Ltd live share price is ₹ 211.97. It is a Small Cap stock and had a market capitalization of ₹ 69,434,376,192.00 as on 12 hours ago.
The registered office of SPARC Ltd is located in Vadodara, Gujarat. The registrar and share transfer agent for SPARC Ltd is Link Intime India Pvt Ltd. The Stock Exchanges on which shares of Sun Pharma Advanced Research Co Ltd is listed includes BSE, NSE, MCX.
SUN PHARMA ADV.RES.CO.LTD
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 409
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
| Address | 17/B, Mahal Industrial Estate, Mumbai, India |
| Country | India |
| Phone | 91 22 6645 5645 |
| Website | https://www.sparc.life |
SPARC Ltd Recent News
No Recent News found for Sun Pharma Advanced Research Co Ltd.